March 01, 2015 8:36 PM ET

Pharmaceuticals

Company Overview of Intra-Cellular Therapies, Inc.

Company Overview

Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the central nervous system (CNS). Its lead product candidate, ITI-007, which is in clinical development for the treatment of exacerbated and residual schizophrenia; bipolar disorders; sleep deficits associated with neurologic and psychiatric disorders; behavioral disturbances associated with dementia, including Alzheimer’s disease; sleep maintenance insomnia; major depressive disorders; and autism spectrum disorders, posttraumatic stress disorder, and intermittent explosive disorder. The company also develops ITI-002 phosphodi...

3960 Broadway

New York, NY 10032

United States

21 Employees

Phone:

212-923-3344

Fax:

212-923-3388

Key Executives for Intra-Cellular Therapies, Inc.

Co-Founder, Chairman, Chief Executive Officer and President
Age: 61
Total Annual Compensation: $1.1M
Co-founder and Vice President of Business Development
Age: 54
Total Annual Compensation: $283.7K
Chief Financial Officer, Principal Accounting Officer, Vice President of Finance and Secretary
Age: 58
Total Annual Compensation: $357.5K
Compensation as of Fiscal Year 2013.

Intra-Cellular Therapies, Inc. Key Developments

Intra-Cellular Therapies, Inc. Presents at RBC Capital Markets Healthcare Conference 2015, Feb-24-2015 02:35 PM

Intra-Cellular Therapies, Inc. Presents at RBC Capital Markets Healthcare Conference 2015, Feb-24-2015 02:35 PM. Venue: The New York Palace Hotel, New York, New York, United States. Speakers: Sharon Mates, Co-Founder, Chairman, Chief Executive Officer and President.

Intra-Cellular Therapies, Inc. Presents at Leerink's Global Healthcare Conference, Feb-11-2015 02:15 PM

Intra-Cellular Therapies, Inc. Presents at Leerink's Global Healthcare Conference, Feb-11-2015 02:15 PM. Venue: Waldorf Astoria New York, New York, New York, United States. Speakers: Sharon Mates, Co-Founder, Chairman, Chief Executive Officer and President.

Intra-Cellular Therapies, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 02:00 PM

Intra-Cellular Therapies, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 02:00 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Sharon Mates, Co-Founder, Chairman, Chief Executive Officer and President.

Similar Private Companies By Industry

Company Name Region
Humco Holding Group, Inc. United States
Fairhaven Health, LLC United States
UCB, Inc. United States
Akorn (New Jersey), Inc. United States
Green Roads of Florida, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Intra-Cellular Therapies, Inc., please visit www.intracellulartherapies.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.